Max Healthcare Institute Ltd

Max Healthcare | 543220

Market Closed

₹1,121.60

+₹0.00 (+1.68%)

As on 19/11/25, 5:07 AM

Market Cap1,07,247.4 CR

Current Price₹1,121.6

High / Low₹1,314.3 / 936.25

PE Ratio99.07

Book Value₹96.5

Dividend Yield0.14%

ROCE13.46%

ROE8.78%

Face Value₹2.00

Current Vol.51,02,278

Average Vol.12,76,53,456

ISININE027H01010

PB Ratio11.36

Debt to Equity0.24

Net Profit Margin15.31

Operating Margin27.47

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001
Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'
Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'
The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspecialty Hospitals facilities
The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 22 network healthcare facilities, which includes BLK Hospital and BNH Hospital
Besides, it provides healthcare services across secondary and tertiary care specialties with key focus on centres of excellence i
, oncology, neurosciences, cardiac sciences, orthopaedics,renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (MAMBS)
In addition to core hospital business, the company has two SBUs, namely, MaxHome and MaxLab
MaxHome is a platform that provides health and wellness services at home
It has 12 service lines, including pathology, pharmacy delivery, physiotherapy and critical care nursing

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI42.83

SMA 201152.90

SMA 501151.02

SMA 1001197.46

SMA 2001149.96

SMA 101116.47

MACD_12_26_Days-16.45

EMA10Day1120.11

EMA20Day1134.99

EMA50Day1155.29

MACD_12_26_9_Days-5.15

EMA100Day1164.91

EMA200Day1137.95

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth30.01%

ROE12.10%

EBITDA Margin27.47%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	7,028.46	5,406.02	4,562.60	3,931.46	2,504.67
Interest	165.02	59.89	83.86	100.87	179.46
Expenses	5,179.66	3,913.90	3,322.07	2,988.90	2,100.81
Financing Profit	2,004.44	1,670.19	1,379.77	1,069.92	518.60
Financing Margin %	29%	31%	30%	27%	21%
Other Income	155.64	178.07	139.24	127.36	114.74
Depreciation	359.42	244.98	232.19	221.12	174.09
Profit before tax	1,406.37	1,365.32	1,063.72	738.90	-68.65
Tax %	23%	23%	-4%	18%	-67%
Net Profit	1,075.88	1,057.64	1,103.51	605.05	-114.50
EPS in Rs	11.07	10.89	11.38	6.25	-1.59

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849	14 Jul ‘25	Purchase	1,37,941	₹1,219	7.01%
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828	14 Jul ‘25	Sell	1,37,941	₹1,219	7.01%
CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD	14 May ‘25	Purchase	2,58,242	₹1,172	17.48%
MORGAN STANLEY ASIA SINGAPORE PTE	14 May ‘25	Sell	2,58,242	₹1,172	17.48%
CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED	28 Aug ‘24	Purchase	6,69,000	₹862	30.27%
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED	28 Aug ‘24	Sell	6,69,000	₹862	30.27%
ISHARES CORE MSCI EMERGING MARKETS ETF	14 Nov ‘22	Purchase	6,99,791	₹445.1	78.18%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	14 Nov ‘22	Sell	6,99,791	₹445.1	78.18%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	5,78,882	₹407.9	19.88%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	5,78,882	₹407.9	19.88%

News

15 Nov 2025 12:00 am

Max Healthcare Institute consolidated net profit rises 74.34% in the September 2025 quarter

15 Nov 2025 12:00 am

Max Healthcare clocks 59% YoY jump in Q2 PAT;

Record Date

Corporate Action

Information

Announcement Day

30 Jul 2025

AGM

24 Jun 2025

04 Jul 2025

Final Dividend (₹1.5)

Recommended final dividend of Rs. 1.5/- per equity share (15% of face value of ? 10/- each), out of the profits of the financial year 2024-25, subject to approval of the Members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting ('AGM'). Intimation of Annual General Meeting, Record Date and Communication to members for deduction of tax at source on final dividend (As Per BSE Announcement Dated on: 24/06/2025)

20 May 2025

20 Sept 2024

AGM

11 Aug 2024

23 Aug 2024

Final Dividend (₹1.5)

Outcome of Board meeting held on May 22, 2024 Recommended final dividend of ?1.5/- per equity share (15% of face value of ? 10 /- each), out of the profits of the financial year 2023-24, subject to approval of the members of the Company,which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting

22 May 2024

27 Sept 2023

AGM

26 Aug 2023

08 Sept 2023

Final Dividend (₹1)

Board recommended final dividend of Re.1 /- per equity share (10% of face value of Rs.10 /- each), out of the profits of the financial year 2022-23, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting.

16 May 2023

26 Sept 2022

AGM

10 Aug 2022

29 Sept 2021

AGM

10 Aug 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
1,118	1,08,720	77	11	60	0	15.31%
7,384	1,06,173	64	12	42	1	6.91%
928	70,037	70	7	50	0	9.98%
1,949	39,827	47	10	34	1	14.42%
680	35,217	95	8	56	0	7.26%
1,190	31,990	54	9	40	0	13.04%
668	26,737	81	12	49	1	13.67%
3,180	26,641	50	11	39	0	20.00%
643	25,901	55	5	28	0	13.62%
1,898	19,241	53	7	43	0	20.28%

Showing 10 of 56 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Max Healthcare Institute Ltd?

The current share price of Max Healthcare Institute Ltd (Max Healthcare) is ₹1121.60. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Max Healthcare Institute Ltd?

The Price-to-Earnings (P/E) ratio of Max Healthcare Institute Ltd is 1121.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has a 52-week high of ₹1314.30 and a 52-week low of ₹936.25. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd offers a dividend yield of 0.14%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Max Healthcare Institute Ltd?

The Earnings Per Share (EPS) of Max Healthcare Institute Ltd is ₹12.34. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has a Return on Equity (ROE) of 8.78%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.